Antimicrobial Treatment of Community-acquired Pneumonia

Overview

Journal Clin Chest Med

Specialty Pulmonary Medicine

Date 2005 Apr 2

PMID 15802167

Citations 2

Authors

Marcos I Restrepo

Antonio Anzueto

Affiliations

Soon will be listed here.

Abstract

Community-acquired pneumonia (CAP) is a clinical diagnosis that has a significant impact on health care management around the world. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with CAP. This article provides a review of recent studies and guidelines addressing antimicrobial therapy for hospitalized patients with CAP.

Citing Articles

Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients.

Lopez-Alcalde J, Rodriguez-Barrientos R, Redondo-Sanchez J, Munoz-Gutierrez J, Molero Garcia J, Rodriguez-Fernandez C Cochrane Database Syst Rev. 2018; 9:CD009070.

PMID: 30188565 PMC: 6513237. DOI: 10.1002/14651858.CD009070.pub2.

The role of procalcitonin in respiratory infections.

Certain L, Schuetz P Curr Infect Dis Rep. 2012; 14(3):308-16.

PMID: 22382693 DOI: 10.1007/s11908-012-0249-5.

References

Hatchette T, Gupta R, Marrie T . Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature. Clin Infect Dis. 2000; 31(6):1349-56. DOI: 10.1086/317486. View

Leroy O, Santre C, Beuscart C, Georges H, Guery B, Jacquier J . A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med. 1995; 21(1):24-31. DOI: 10.1007/BF02425150. View

Arancibia F, Ewig S, Martinez J, Ruiz M, Bauer T, Marcos M . Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med. 2000; 162(1):154-60. DOI: 10.1164/ajrccm.162.1.9907023. View

Martinez J, Horcajada J, Almela M, Marco F, Soriano A, Garcia E . Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2003; 36(4):389-95. DOI: 10.1086/367541. View

Afessa B, Green B . Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest. 2000; 117(4):1017-22. DOI: 10.1378/chest.117.4.1017. View

Kalin M, Ortqvist A, Almela M, Aufwerber E, Dwyer R, Henriques B . Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis. 2000; 182(3):840-7. DOI: 10.1086/315760. View

Garcia-Ordonez M, Paez F, Alvarez F, Poyato B, Franquelo M, Colmenero J . Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 2001; 20(1):14-9. DOI: 10.1007/s100960000413. View

Dudas V, Hopefl A, Jacobs R, Guglielmo B . Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother. 2000; 34(4):446-52. DOI: 10.1345/aph.19174. View

Fine M, Auble T, Yealy D, Hanusa B, Weissfeld L, Singer D . A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336(4):243-50. DOI: 10.1056/NEJM199701233360402. View

10.

Moroney J, Fiore A, Harrison L, Patterson J, Farley M, Jorgensen J . Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis. 2001; 33(6):797-805. DOI: 10.1086/322623. View

11.

Luna C, Famiglietti A, Absi R, Videla A, Nogueira F, Fuenzalida A . Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest. 2000; 118(5):1344-54. DOI: 10.1378/chest.118.5.1344. View

12.

Ewig S, Schafer H, Torres A . Severity assessment in community-acquired pneumonia. Eur Respir J. 2001; 16(6):1193-201. DOI: 10.1034/j.1399-3003.2000.16f27.x. View

13.

Mehta R, Groth M . Clinical application of a prognostic model for severe community-acquired pneumonia. Chest. 2001; 119(1):312-3. DOI: 10.1378/chest.119.1.312. View

14.

Metlay J, Fine M . Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med. 2003; 138(2):109-18. DOI: 10.7326/0003-4819-138-2-200301210-00012. View

15.

Meehan T, Fine M, Krumholz H, Scinto J, Galusha D, Mockalis J . Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997; 278(23):2080-4. View

16.

Pascual F, Matthay M, Bacchetti P, Wachter R . Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation. Chest. 2000; 117(2):503-12. DOI: 10.1378/chest.117.2.503. View

17.

Niederman M, Mandell L, Anzueto A, Bass J, Broughton W, Campbell G . Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001; 163(7):1730-54. DOI: 10.1164/ajrccm.163.7.at1010. View

18.

Fogarty C, Greenberg R, Dunbar L, Player R, Marrie T, Kojak C . Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials. Clin Ther. 2001; 23(3):425-39. DOI: 10.1016/s0149-2918(01)80047-3. View

19.

Mandell L, Bartlett J, Dowell S, File Jr T, Musher D, Whitney C . Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003; 37(11):1405-33. PMC: 7199894. DOI: 10.1086/380488. View

20.

Marik P . Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001; 344(9):665-71. DOI: 10.1056/NEJM200103013440908. View